__timestamp | HUTCHMED (China) Limited | Travere Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 19764000 | 27632226 |
Thursday, January 1, 2015 | 67426000 | 97707000 |
Friday, January 1, 2016 | 59752000 | 129037000 |
Sunday, January 1, 2017 | 65383000 | 151332000 |
Monday, January 1, 2018 | 70165000 | 158719000 |
Tuesday, January 1, 2019 | 44738000 | 170104000 |
Wednesday, January 1, 2020 | 39457000 | 192195000 |
Friday, January 1, 2021 | 97894000 | 220706000 |
Saturday, January 1, 2022 | 115306000 | 204426000 |
Sunday, January 1, 2023 | 453552000 | 133788000 |
Unlocking the unknown
In the dynamic world of pharmaceuticals, understanding financial trends is crucial. This analysis delves into the gross profit trajectories of HUTCHMED (China) Limited and Travere Therapeutics, Inc. over the past decade. From 2014 to 2023, HUTCHMED's gross profit surged by an impressive 2,200%, peaking in 2023. In contrast, Travere Therapeutics experienced a more modest growth of approximately 384% during the same period, with its highest profit recorded in 2021.
These insights highlight the contrasting growth strategies and market responses of these two industry players.
Key Insights on Gross Profit: Sanofi vs Travere Therapeutics, Inc.
Zoetis Inc. vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs HUTCHMED (China) Limited
Gross Profit Trends Compared: Incyte Corporation vs HUTCHMED (China) Limited
Viatris Inc. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Gross Profit Comparison: Bio-Techne Corporation and Travere Therapeutics, Inc. Trends
Gross Profit Comparison: Pharming Group N.V. and HUTCHMED (China) Limited Trends
Pharming Group N.V. vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
HUTCHMED (China) Limited vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown